MATTHEW IANDOLI: Open Payments
NPI 1407419344 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 87 payments from 12 companies in 2025. Trend: 2023 $436 · 2024 $502 · 2025 $1,618
Food & beverage: $1,509Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $541 |
| ABBVIE INC. | 21 | $217 |
| Alkermes, Inc. | 10 | $197 |
| E.R. Squibb & Sons, L.L.C. | 10 | $170 |
| Neurocrine BioSciences, Inc. | 8 | $144 |
| Otsuka America Pharmaceutical, Inc. | 4 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: UZEDY, ARISTADA, VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, REXULTI, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
